Low-dose Gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.

July 17, 2019 updated by: Paul Farand, Université de Sherbrooke

Low-dose, EKG-gated CT Validity for the Evaluation of Ascendant Aortic Aneurysm.

We will demonstrate the validity of measurements with a low-dose, EKG-gated CT without contrast in the ascending aorta evaluation, compared with the current Angio-CT measurements.

Study Overview

Detailed Description

The actual protocol used in aorta evaluation consist of two CT-scans on the same study. The first scan that detects calcifications is using parameters with low-dose current, non EKG-gated and without contrast. The second scan uses iodine-contrast, EKG-gating and higher current dose to obtain higher image quality of diagnostic value.

The study will optimize the first scan parameters and compare the measures of the aorta diameters from the standard protocol.

By modifying the first scan parameters, we would demonstrate that the follow-up of an aortic aneurysm can safely be made with lower radiation exposure.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Sherbrooke, Quebec, Canada, J1H5N4
        • Sherbrooke University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 60 years old and more
  • 85 bpm or less

Exclusion Criteria:

  • aortic material
  • EKG gating not possible
  • aorta pathology (thrombus, dissection)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Subjects awaiting for an aortic evaluation

Subjects already waiting for an aortic evaluation, either a first diagnostic scan or follow-up of a known aneurysm.

Each subjects will have the two CT-scans on the same day.

On the same day, the subject will do :

  1. Modified low-dose, EKG-gated CT without contrast
  2. Usual high-dose, EKG-gated CT with contrast

Comparing aortic diameters from the two protocols.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measures validity (aorta diameter in mm from scan images)
Time Frame: 12 months
Comparing aorta diameters from the two modalities.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiation (in msev from scanner report)
Time Frame: 12 months
Comparing radiation exposure with the two modalities
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Paul Farand, Université de Sherbrooke

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2017

Primary Completion (Actual)

April 30, 2019

Study Completion (Actual)

May 30, 2019

Study Registration Dates

First Submitted

April 2, 2017

First Submitted That Met QC Criteria

April 8, 2017

First Posted (Actual)

April 13, 2017

Study Record Updates

Last Update Posted (Actual)

July 18, 2019

Last Update Submitted That Met QC Criteria

July 17, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2016-1074

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ascendant Aortic Aneurysm

Subscribe